| Dr Brian Douglas Biggers, MD | |
|
1500 N Oakland Ave, Bolivar, MO 65613-3011 | |
| (417) 326-6000 | |
| Not Available |
| Full Name | Dr Brian Douglas Biggers |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 1500 N Oakland Ave, Bolivar, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447474762 | NPI | - | NPPES |
| 204163307 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M9864 (Texas) | Secondary |
| 208600000X | Surgery | 2002011762 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 8628092897 | 219 |
News Archive
PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE's revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.
The Substance Abuse and Mental Health Services Administration (SAMHSA) will unveil the results of the latest (2009) National Survey on Drug Use and Health (NSDUH) at a press conference on Thursday, September 16. The annual survey is the largest of its kind, and is the government's primary vehicle for determining how many persons are abusing illegal drugs, pharmaceuticals, alcohol and tobacco.
Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 3 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760405864 PECOS PAC ID: 8628092897 Enrollment ID: O20060116000342 |
News Archive
PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE's revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.
The Substance Abuse and Mental Health Services Administration (SAMHSA) will unveil the results of the latest (2009) National Survey on Drug Use and Health (NSDUH) at a press conference on Thursday, September 16. The annual survey is the largest of its kind, and is the government's primary vehicle for determining how many persons are abusing illegal drugs, pharmaceuticals, alcohol and tobacco.
Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Douglas Biggers, MD 1001 E Primrose St, Springfield, MO 65807-5155 Ph: (417) 875-3758 | Dr Brian Douglas Biggers, MD 1500 N Oakland Ave, Bolivar, MO 65613-3011 Ph: (417) 326-6000 |
News Archive
PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE's revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.
The Substance Abuse and Mental Health Services Administration (SAMHSA) will unveil the results of the latest (2009) National Survey on Drug Use and Health (NSDUH) at a press conference on Thursday, September 16. The annual survey is the largest of its kind, and is the government's primary vehicle for determining how many persons are abusing illegal drugs, pharmaceuticals, alcohol and tobacco.
Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.
Viral Genetics, Inc. today announced that it has changed its name to VG Life Sciences Inc. and that it has completed its 1-for-600 reverse stock split, both of which will take effect at the open of trading on November 27, 2012.
› Verified 3 days ago
Brent Allen Bartgis, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 W Parkview, Suite 1f, Bolivar, MO 65613 Phone: 417-326-8700 Fax: 417-777-8173 | |
Dr. Walter Wayne Wolf Iii, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 W Parkview St, Suite 1f, Bolivar, MO 65613 Phone: 417-326-8700 Fax: 417-777-8173 | |
Dr. Martin S. Tyson, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 W Parkview St, Suite 1g, Bolivar, MO 65613 Phone: 417-326-8700 Fax: 417-328-6755 |